2329 — Glory Health Industry Income Statement
0.000.00%
Last trade - 00:00
- HK$146.67m
- HK$26.92bn
- CNY2.51bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 8,093 | 5,769 | 9,898 | 3,905 | 2,506 |
Cost of Revenue | |||||
Gross Profit | 2,139 | 1,045 | 1,247 | 114 | -50.3 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5,622 | 4,999 | 8,816 | 4,323 | 2,551 |
Operating Profit | 2,471 | 770 | 1,082 | -419 | -44.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2,046 | 517 | 877 | -1,090 | -679 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,220 | 134 | 345 | -995 | -594 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 860 | 98.7 | 228 | -913 | -564 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 860 | 98.7 | 228 | -913 | -564 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.197 | 0.023 | 0.003 | -0.204 | -0.14 |
Dividends per Share |